Universe Pharmaceuticals ( (UPC) ) has issued an announcement.
On March 1, 2025, Universe Pharmaceuticals Inc attempted to hold an extraordinary general meeting of shareholders, but it was adjourned due to a lack of quorum. The meeting has been rescheduled for March 8, 2025, at the company’s principal offices in Ji’an, China. This adjournment may impact the company’s operational plans and decision-making processes, potentially affecting stakeholders awaiting outcomes from the meeting.
More about Universe Pharmaceuticals
Universe Pharmaceuticals Inc is a company operating in the pharmaceutical industry, primarily engaged in the development and distribution of pharmaceutical products. The company is based in Ji’an, Jiangxi, China, and focuses on serving the healthcare market with its range of medicinal offerings.
YTD Price Performance: -80.25%
Average Trading Volume: 14,132,204
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.11M
For a thorough assessment of UPC stock, go to TipRanks’ Stock Analysis page.